Chondrogenic potential of mesenchymal stromal cells derived from equine bone marrow and umbilical cord blood
Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt
Standard
Chondrogenic potential of mesenchymal stromal cells derived from equine bone marrow and umbilical cord blood. / Berg, Lise Charlotte; Koch, Thomas Gadegaard; Heerkens, T.; Besonov, K.; Thomsen, Preben Dybdahl; Betts, D.H.
I: Veterinary and Comparative Orthopaedics and Traumatology, Bind 22, Nr. 5, 2009, s. 363-370.Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt
Harvard
APA
Vancouver
Author
Bibtex
}
RIS
TY - JOUR
T1 - Chondrogenic potential of mesenchymal stromal cells derived from equine bone marrow and umbilical cord blood
AU - Berg, Lise Charlotte
AU - Koch, Thomas Gadegaard
AU - Heerkens, T.
AU - Besonov, K.
AU - Thomsen, Preben Dybdahl
AU - Betts, D.H.
PY - 2009
Y1 - 2009
N2 - Objective: Orthopaedic injury is the most common cause of lost training days or premature retirement in the equine athlete. Cell-based therapies are a potential new treatment option in musculo-skeletal diseases. Mesenthymal stromal cells (MSC) have been derived from multiple sources in the horse including bone marrow and umbilical cord blood. The objective of this study was to provide an in vitro comparison of the chondrogenic potential in MSC derived from adult bone marrow (BM-MSC) and umbilical cord blood (CB-MSC).Results: MSC from both sources produced tissue with cartilage-like morphology that stained positive for proteoglycans and expressed cartilage markers. The CB-MSC pellets were larger and showed hyaline-like cartilage morphology as early as day six. Gene expression of collagen type 21, aggrecan and CD-RAP was higher in CB- than BM-MSC pellets. Expression of Sox9 mRNA was similar between CB- and BM-MSC pellets. Protein concentration of cartilage-derived retinoic acid sensitive protein was higher in culture medium from CB- than BM-MSC pellets.Conclusion: CB-MSC and BM-MSC were both capable of producting hyaline-like cartilage in vitro. Howeverm, in this study the MSC from umbilical cord blood appeared to have more chondrogenic potential than the BM-MSC based on the cells tested and parameters measured.
AB - Objective: Orthopaedic injury is the most common cause of lost training days or premature retirement in the equine athlete. Cell-based therapies are a potential new treatment option in musculo-skeletal diseases. Mesenthymal stromal cells (MSC) have been derived from multiple sources in the horse including bone marrow and umbilical cord blood. The objective of this study was to provide an in vitro comparison of the chondrogenic potential in MSC derived from adult bone marrow (BM-MSC) and umbilical cord blood (CB-MSC).Results: MSC from both sources produced tissue with cartilage-like morphology that stained positive for proteoglycans and expressed cartilage markers. The CB-MSC pellets were larger and showed hyaline-like cartilage morphology as early as day six. Gene expression of collagen type 21, aggrecan and CD-RAP was higher in CB- than BM-MSC pellets. Expression of Sox9 mRNA was similar between CB- and BM-MSC pellets. Protein concentration of cartilage-derived retinoic acid sensitive protein was higher in culture medium from CB- than BM-MSC pellets.Conclusion: CB-MSC and BM-MSC were both capable of producting hyaline-like cartilage in vitro. Howeverm, in this study the MSC from umbilical cord blood appeared to have more chondrogenic potential than the BM-MSC based on the cells tested and parameters measured.
U2 - 10.3415/VCOT-08-10-0107
DO - 10.3415/VCOT-08-10-0107
M3 - Journal article
C2 - 19750290
VL - 22
SP - 363
EP - 370
JO - Veterinary and Comparative Orthopaedics and Traumatology
JF - Veterinary and Comparative Orthopaedics and Traumatology
SN - 0932-0814
IS - 5
ER -
ID: 15376380